Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel O Zhuchenko, J Bailey, P Bonnen, T Ashizawa, DW Stockton, C Amos, ... Nature genetics 15 (1), 62-69, 1997 | 1901 | 1997 |
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome P Trouillas, T Takayanagi, M Hallett, RD Currier, SH Subramony, ... Journal of the neurological sciences 145 (2), 205-211, 1997 | 1420 | 1997 |
Mutations in Kir2. 1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome NM Plaster, R Tawil, M Tristani-Firouzi, S Canún, S Bendahhou, ... Cell 105 (4), 511-519, 2001 | 1189 | 2001 |
Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3 HL Paulson, MK Perez, Y Trottier, JQ Trojanowski, SH Subramony, ... Neuron 19 (2), 333-344, 1997 | 1009 | 1997 |
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia T Zu, Y Liu, M Bañez-Coronel, T Reid, O Pletnikova, J Lewis, TM Miller, ... Proceedings of the National Academy of Sciences 110 (51), E4968-E4977, 2013 | 858 | 2013 |
Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale SH Subramony, W May, D Lynch, C Gomez, K Fischbeck, M Hallett, ... Neurology 64 (7), 1261-1262, 2005 | 374 | 2005 |
The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients KP Patel, TW O'Brien, SH Subramony, J Shuster, PW Stacpoole Molecular genetics and metabolism 106 (3), 385-394, 2012 | 368 | 2012 |
A novel X–linked gene, DDP, shows mutations in families with deafness (DFN–1), dystonia, mental deficiency and blindness H Jin, M May, L Tranebjærg, E Kendall, G Fontán, J Jackson, ... Nature genetics 14 (2), 177-180, 1996 | 296 | 1996 |
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial EJ Sorenson, AJ Windbank, JN Mandrekar, WR Bamlet, SH Appel, ... Neurology 71 (22), 1770-1775, 2008 | 278 | 2008 |
Gametic and somatic tissue–specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1 SS Chong, AE McCall, J Cota, SH Subramony, HT Orr, MR Hughes, ... Nature genetics 10 (3), 344-350, 1995 | 235 | 1995 |
Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset LPW Ranum, MY Chung, S Banfi, A Bryer, LJ Schut, R Ramesar, ... American journal of human genetics 55 (2), 244, 1994 | 223 | 1994 |
Measuring Friedreich ataxia: complementary features of examination and performance measures DR Lynch, JM Farmer, AY Tsou, S Perlman, SH Subramony, CM Gomez, ... Neurology 66 (11), 1711-1716, 2006 | 208 | 2006 |
Dystrophinopathy in isolated cases of myopathy in females EP Hoffman, K Arahata, C Minetti, E Bonilla, LP Rowland, C Angelini, ... Neurology 42 (5), 967-967, 1992 | 189 | 1992 |
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN P Hogarth, A Gregory, MC Kruer, L Sanford, W Wagoner, MR Natowicz, ... Neurology 80 (3), 268-275, 2013 | 182 | 2013 |
Consensus-based care recommendations for adults with myotonic dystrophy type 1 T Ashizawa, C Gagnon, WJ Groh, L Gutmann, NE Johnson, G Meola, ... Neurology: Clinical Practice 8 (6), 507-520, 2018 | 171 | 2018 |
A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy PC Scacheri, EP Hoffman, JD Fratkin, C Semino–Mora, A Senchak, ... Neurology 55 (11), 1689-1696, 2000 | 167 | 2000 |
Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study) DR Lynch, MP Chin, MB Delatycki, SH Subramony, M Corti, JC Hoyle, ... Annals of neurology 89 (2), 212-225, 2021 | 166 | 2021 |
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study T Ashizawa, KP Figueroa, SL Perlman, CM Gomez, GR Wilmot, ... Orphanet journal of rare diseases 8, 1-8, 2013 | 158 | 2013 |
Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation … TA Zesiewicz, G Wilmot, SH Kuo, S Perlman, PE Greenstein, SH Ying, ... Neurology 90 (10), 464-471, 2018 | 151 | 2018 |
Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia DR Lynch, J Farmer, L Hauser, IA Blair, QQ Wang, C Mesaros, N Snyder, ... Annals of clinical and translational neurology 6 (1), 15-26, 2019 | 136 | 2019 |